跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRO-ZOLPIDEM ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRO-ZOLPIDEM ODT
Authorized
STANDARD
PRO-ZOLPIDEM ODT
PRO DOC LIMITEE
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
dd5e17eb604abfcc
Company
PRO DOC LIMITEE
Type
Standard
Approval Details
Approval Id
dd5e17eb604abfcc
Drug Approval Canada Name
PRO-ZOLPIDEM ODT
Product Name
PRO-ZOLPIDEM ODT
Status
Marketed
Status Date
2023-10-30
Original Market Date
2023-10-30
Din
02537346
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Sublingual
Schedule
Targeted (CDSA IV)
Ahfs
28:24.92
Atc Original
N05CF02 ZOLPIDEM
Atc Name
n 05 cf 02
Aig Number
0122857001
Company Name
PRO DOC LIMITEE
Company Address
2925 Boulevard Industriel, Laval, Quebec, Canada, H7L 3W9
Active Ingredients
ZOLPIDEM TARTRATE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
dd5e17eb604abfcc
Type
Standard
Back to Health Canada Approvals